PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate ...

As decentralized and flexible clinical trial models mature, they have become an established component of research and ...

On Sept. 18, 2024, the U.S. Food & Drug Administration (FDA) issued a final guidance document titled “Conducting Clinical Trials With Decentralized Elements, Guidance for Industry, Investigators, and ...

Key market opportunities in decentralized clinical trials include increased adoption of hybrid trial designs, AI-driven optimization, and virtual trial platforms driven by telemedicine and digital ...

As demand from sponsors and CROs for proven, large‑scale remote patient monitoring (RPM) capabilities continues to ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT ...

Decentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health Decentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic ...

Please provide your email address to receive an email when new articles are posted on . FDA issued guidance on decentralized elements of clinical trials last fall. Investigators need to balance using ...

This is the fifth edition of our blog series on decentralized clinical trials DCTs. Click here to explore the series. The COVID-19 Pandemic required the health care industry to adapt to accommodate ...